[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
July 28, 1999

Drug Safety Takes Cooperation

Author Affiliations

Not Available

Not Available

JAMA. 1999;282(4):315-316. doi:10.1001/jama.282.4.315-JMN0728-3-1

Washington—Reducing the number of adverse drug reactions in the United States will take a concerted effort on the part of everyone involved, not just pharmaceutical manufacturers and regulators but physicians, patients, policymakers, and health plan administrators. New direction and leadership at the highest level are needed if drug safety is to be ensured, said participants in a symposium on drug safety held here last month by the Center for Drug Development Science at Georgetown University Medical Center.

First Page Preview View Large
First page PDF preview
First page PDF preview